Division of Abiomed Inc./Abiomed Cardiovascular Inc.
Latest From Iomed Inc.
Myrexis, a biotech company developing small molecule compounds with novel chemical structures and distinct mechanisms of action, has decided to keep its interim president and CEO, Robert Lollini, in place as permanent CEO and a member of the board. Mr Lollini was also previously the company's CFO, a role which has now been filled by Andrea Kendell. Mr Lollini joined Myrexis in 2009 from Iomed, and Ms Kendell, who previously served at Moog Medical Devices Group, was most recently Myrexis' vice-president of finance and human resources.
The drug delivery device industry is on track to reach almost $23 billion by the year 2011, and the fastest growth will come from the transdermal sector. According to a recent Windhover Information/Medtech Insight report, transdermal delivery technologies will build up to sales of $4.6 billion by 2011. Pharma's increasing fondness for macromolecules will fuel that growth, as will the perennially hot market for transdermal formulations of pain drugs.
Transdermal drug delivery has come a long way since the first patch for seasickness. In a drug delivery device industry on track to reach almost $23 billion by the year 2011 (according to "US Markets for Drug and Fluid Delivery Devices," published in October 2007 by Windhover Information's Medtech Insight division) the transdermal sector will grow at a faster rate than injection or inhalation drug delivery systems. Transdermal delivery technologies will grow at a compound annual rate of more than 11% over the next four years, building up to sales of $3.5 billion in the year 2011.
With the aging of the population, heart failure has emerged as a key public health concern. Several device-based technologies are poised to positively impact both ends of the disease spectrum, enabling earlier diagnosis and treatment, and providing more treatment options for those in later stages of the disease.
- Site Specific
- Drug Delivery
- Therapeutic Areas
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- Abiomed Inc.
- Colfax Corp.
- Senior Management
Robert Lollini, Pres. & CEO
Brian L Mower, CFO
Jessica Barrett, Dir., Sales & Mktg.
- Contact Info
Phone: (801) 975-1191
2441 S. 3850 W, Ste. A
Salt Lake City, UT 84120-9941
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.